East Tennessee State University

Digital Commons @ East Tennessee State University
Undergraduate Honors Theses

Student Works

5-2020

Gut Pathophysiology in Mouse Models of Social Behavior Deficits
Kyla Scott

Follow this and additional works at: https://dc.etsu.edu/honors
Part of the Bacterial Infections and Mycoses Commons, Digestive System Commons, Digestive
System Diseases Commons, Immune System Diseases Commons, Medical Anatomy Commons, Medical
Biochemistry Commons, Medical Microbiology Commons, Medical Pathology Commons, Microbiology
Commons, Tissues Commons, and the Virus Diseases Commons

Recommended Citation
Scott, Kyla, "Gut Pathophysiology in Mouse Models of Social Behavior Deficits" (2020). Undergraduate
Honors Theses. Paper 544. https://dc.etsu.edu/honors/544

This Honors Thesis - Withheld is brought to you for free and open access by the Student Works at Digital Commons
@ East Tennessee State University. It has been accepted for inclusion in Undergraduate Honors Theses by an
authorized administrator of Digital Commons @ East Tennessee State University. For more information, please
contact digilib@etsu.edu.

1

Gut Pathophysiology in Mouse Models of Social Behavior Deficits
By
Kyla Scott
An Undergraduate Thesis Submitted in Partial Fulfillment
of the Requirements for the
University Honors Scholars Program,
Honors College,
and the
Honors-in-Discipline Human Health Program
College of Public Health
East Tennessee State University

4-21-20
Kyla Scott
_______________________________________________

Kyla Scott

Date

4/21/2020
_______________________________________________
Dr. Michelle Chandley, Thesis Mentor

Date

4/21/2020
_______________________________________________

Dr. Sean Fox, Second Reader

Date

2

Table of Contents
ACKNOWLEDGEMENTS ........................................................................................................................... 3
ABSTRACT .................................................................................................................................................. 4
INTRODUCTION ......................................................................................................................................... 6

CHARACTERISTICS OF ASD .................................................................................. 6
GUT MICROBIOME ................................................................................................ 8
MICROBIOME-GUT-BRAIN AXIS ........................................................................ 10
MOUSE MODELS ................................................................................................. 19
HYPOTHESIS ........................................................................................................ 22
METHODS ................................................................................................................................................. 24

ANIMAL CARE ...................................................................................................... 24
MARBLE BURYING ............................................................................................... 24
SOCIAL TESTING .................................................................................................. 25
FECAL COLLECTION ............................................................................................ 25
SHORT-CHAIN FATTY ACID ASSAY ...................................................................... 25
STATISTICAL ANALYSIS OF SHORT CHAIN FATTY ACID DATA ............................. 26
INTESTINAL PREPARATION .................................................................................. 26
HEMATOXYLIN AND EOSIN STAINING .................................................................. 27
IMAGE ACQUISITION AND TISSUE MEASUREMENTS ............................................. 28
RESULTS ................................................................................................................................................... 29

BEHAVIORAL STUDIES ........................................................................................ 29
SHORT CHAIN FATTY ACID ASSAYS................................................................... 31
INTESTINAL MORPHOLOGY MEASUREMENTS ................................................... 34
DISCUSSION ............................................................................................................................................. 40

BEHAVIORAL STUDIES ........................................................................................ 40
SHORT CHAIN FATTY ACID ASSAYS................................................................... 42
INTESTINAL MORPHOLOGY ................................................................................ 44
LIMITATIONS....................................................................................................... 45
CONCLUSIONS ..................................................................................................... 45
APPENDIX ................................................................................................................................................. 47
WORKS CITED ......................................................................................................................................... 65

3
ACKNOWLEDGEMENTS
Thank you to everyone who has helped me along the way, starting with Dr. Chandley and the lab
squad: Brooke Beasley, Ryan Abbens, Sarah Parkinson, Misty Owens, Gethien Andrew, Allie
Dougan, Emma Self, Ben Curtis and Heba Al-Khateeb. I would like to give a special thank you
to Brooke, Sarah, and Ben for their help with the mice and intestinal tissue, to John Sterrett and
Dr. Andrew Clark for their knowledge and work with the short-chain fatty acid assays, and to
Sophia Fledderman, Lilith Bulawa, and Dr. Allan Forsman for their help with staining and
imaging.

Thank you to Dr. Sean Fox for being my second reader.

Additionally, thank you to the ETSU College of Public Health’s and Quillen College of
Medicine’s research labs and all the people who helped me take care of the mice.

Thank you to the ETSU Honors College and NIH for the funding that made these projects
possible, and to Dr. Karen Kornweibel and Dr. Michael Whitelaw for their guidance for the
thesis writing process.

4
ABSTRACT
Autism spectrum disorders (ASD) encompass neurodevelopment disorders characterized
by atypical patterns of development that impact multiple areas of functioning beginning in early
childhood. The etiology of ASD is unknown and there are currently no preventative treatment
options. Gastrointestinal symptoms are commonly associated comorbidities. The microbiota-gutbrain axis is a multidirectional communication chain that connects the central and enteric
nervous system that relates brain function to peripheral intestinal functions. Changes within this
axis have been postulated in ASD. For example, the “leaky gut theory” proposes that chronic
inflammation is linked to alterations in the bacterial profiles of the gut microbiome and
subsequent shifts in the amount and type of short-chain fatty acids produced can affect
downstream neuronal development. Short-chain fatty acids are signaling molecules produced by
bacteria that can trigger nerve afferents in the gut. Dysbiosis causes altered signaling patterns
that can be identified by altered intestinal morphology. In this study, C57BL/6J control mice and
three mouse models of social behavioral deficits were used to investigate markers of intestinal
pathophysiology. Fecal and intestinal samples were collected from adult wild type control mice
and the social deficit groups of BTBR genetic knockout mice, C57BL/6J mice injected with
valproic acid, and C57BL/6J mice injected with polyinosinic–polycytidylic acid. Short-chain
fatty acid profiles that included acetic, propionic, isobutyric, butyric, isovaleric, and valeric acids
were obtained from fecal samples to determine differences between the models and control mice.
The profiles of the BTBR genetic knockout and valproic acid models were found to be
significantly different from control mice. Additionally, postmortem intestinal ileum samples
underwent hematoxylin and eosin identification procedures to determine the thickness of the
tunica muscularis and tunica mucosa. The thickness of the tunica muscularis was reduced in the
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valproic acid group compared to the wild type control mice in early stages of development
(p=0.0279). This research may illuminate developmental cues that attribute to autism spectrum
disorders and may provide markers to assess future therapeutic treatments.
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INTRODUCTION
Characteristics of ASD
Autism Spectrum Disorders (ASD) encompass neurodevelopment disorders characterized
by atypical patterns of development that impact multiple areas of functioning beginning in early
childhood. There are two traditional patterns of the onset of autism: onset prototype, where
children show slight abnormalities in social and communicative development in the first year of
life and get progressively worse, and regressive autism, where children show normal
developmental cues for the first one or two years of life and then show regression in
communication and social abilities (Ozonoff et al, 2008). Evidence suggests that the most
common time of onset is around the second year of life (Martínez-Pedraza & Carter, 2009). The
diagnostic criteria for ASD requires a child to have symptoms that fall in at least one of the
following social behavior domains. The first domain is that the child must have qualitative
impairment in social interaction which can include impairment in nonverbal behaviors such as
limiting eye contact or abnormal gaze, abnormal facial expression, or abnormal body posturing;
or difficulties in forming relationships and social/emotional reciprocity. The second domain is
qualitative impairment in communication such as being on a nonverbal spectrum, using
stereotyped or repetitive language, or lack of spontaneous play. The third domain is the presence
is restrictive receptive and stereotyped patterns of behavior, interests, and activities such as a
fixation on a specific topic that permeates most of their interests or repetitive hand motions
(Martínez-Pedraza & Carter, 2009).
Autism disorders have a wide range of severity; therefore, they are called "autism
spectrum disorders" or "ASD". They are lifelong disorders that exist in all ethnic, racial, and
economic groups. However, they are more common in white populations than Hispanic or
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African American populations (Biao et al, 2018). Although debatable, ASD is believed to be
around 4 times more prevalent in males (Werling & Geschwind, 2013). ASD may present
differently between the sexes, with girls having more internalized personality-related symptoms
while boys have more externalized behavioral symptoms that are easier to diagnose (Werling &
Geschwind, 2013). Genetic and hormonal differences could also play a role. For example, higher
gestational testosterone levels are linked to the increased prevalence in males (Ruta et al, 2011).
Overall, 1 in 59 children in the United States has been diagnosed with ASD by age 8. The
prevalence in the United States has been increasing. In 2000, the prevalence of autism in eightyear-old populations was 6.7 diagnoses per 1000 children, but in 2014 it was 16.8 in 1000 (Baio
et al, 2014). The etiology of ASD is unknown, but rates are increasing in the United States as
well as globally. It is thought that increased awareness among medical professionals has
contributed to an increased ASD diagnosis. Less stringent criteria for diagnosing ASD in early
versions of the Diagnostic and Statistical Manual of Mental Disorders versions may have
elevated the likelihood of an ASD being diagnosed. Support of this theory exists from research
that shows irregularities in prevalence between states with increased awareness despite the
population being fairly homologous (Wright, 2017). It is even shown that states with better
resources and awareness campaigns are more likely to have higher calculated prevalence
(Wright, 2017). However, overall it is still likely that ASD is underdiagnosed, even with the
numbers increasing (Charman, 2002). Changes in diagnostic methodology do not fully explain
the dramatic increase in prevalence, and it is likely that external environmental factors are behind
the unexplained increase (Van den Hazel et al, 2008).
Associated total cost to diagnose and treat autistic patients has increased with the
increasing prevalence of the disorder. Compared to adolescents without ASD, ASD children's
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medical expenditures are 4.1 to 6.2 times greater (Qi et al, 2016; Shimbukuro et al, 2008).
Intensive behavioral interventions for a child with ASD range from $40,000 to $60,000 per year
per child on average (Rogge & Janssen et al, 2019). The direct and indirect costs including the
cost of medical care, special education, and lost parental productivity totaled between $11.5
billion and $60.9 billion in 2011 (Lavelle et al, 2014).
The etiology or cause of ASD has yet to be defined. Because the etiology is unknown and
there are no known measures that can be taken to prevent a child from developing autism. There
are only therapeutic or behavioral treatments that focus on managing symptoms. ASD is believed
to be caused by a combination of both environmental and genetic factors. Monozygotic twins do
not always both present with ASD. In a recent study of 40 twin pairs, the probandwise
concordance for male monozygotic twins was 0.58 while the concordance between dizygotic
pairs was 0.27. Female twin pairs had similar results. The results show that ASD has moderate
genetic heritability, but not complete heritability (Hallmayer et al, 2011), and no single gene
contributes to the onset (Zeidán-Chuliá et al, 2013; Buxbaum, 2009). The relationship between
genetics, person, and environment must be collectively taken into account to fully understand the
etiology of ASD. Mouse models are often used in experimentation to help demonstrate the
difference between environmental and genetic contributing factors (Ellegood & Crawley, 2015;
Ellegood et al, 2015).
Gut Microbiome
The possible environmental component of autism spectrum disorder may be illuminated
through the connection between the gut microbiome, intestines, and neurodevelopment. Within
the human gut lives trillions of microorganisms that can be broken down into tens of thousands
of bacterial species with more than three million different genes that outnumber the entire human
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genome. Gut bacteria can be beneficial to the body and are fundamental to digestive system
function, but pathogenic bacteria or an unbalanced microbiome can be detrimental to human
health (Sender et al, 2016). The gut's function is tied closely with the limbic system which is
responsible for emotional control (Jones et al, 2006). Changes in the microbiome have been
identified in neuropsychiatric conditions like depression, anxiety, and Parkinson's disease.
Likewise, microbiome differences have been reported in animals that have exposed to
environmental alterations during gestation that later display behavioral differences. It is likely
that there are critical developmental windows in the prenatal environment and early postnatal
stages of development for colonization by the correct ratio of beneficial bacteria (Warner, 2019;
Dinan & Cryan, 2017). While the "microbiota fingerprint" can vary up to 50% between
individuals, patients with similar disorders like autism tend to have more similarities to each
other than to unaffected individuals (Clemente et al, 2012).
Advancing research has shown that the intrauterine environment during gestation is not
likely sterile like previously thought. Recently, a diverse pattern of bacteria has been cultured
from meconium, an infant's first stool, and is thought to represent the bacterial profile of the
intrauterine environment. Also, epidemiological studies have shown a correlation between early
colonization of the gut and pre-term delivery with worse neonatal outcomes. The largest and
most important sources of bacterial colonization of infants happens during vaginal or cesarean
birth. The fetal gut is nearly sterile until immediately after birth when the gut is colonized and
within hours after birth the stool will contain bacteria. Gut colonization begins with primarily
facultative anaerobes such as Escherichia and Enterococcus because the gut has positive
oxidation/reduction potential, meaning that there is oxygen available for the bacteria to use.
However, as the oxygen is consumed over time, the environment is more reduced and strict
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anaerobes including Firmicutes such as Clostridia and Bacteroidetes such as Bifodobacteria that
do not require oxygen begin colonizing (Penders et al, 2006; Houghteling & Walker, 2015). The
early microbiome is called the pioneer microbiome and it is important because it establishes the
gut and microbiome's relationship with the developing immune system and the future
colonization of the gut (Houghteling & Walker, 2015). It has been suggested that changes in a
single species profile during infancy can have lasting, permanent effects a child's microbiome
health and immune system development causing chronic inflammation, allergies, and
inflammatory bowel disease (Gaufin et al, 2018), and the development of diseases such as Type
II Diabetes and obesity (Vael & Desager, 2009; Gaufin et al, 2018; Cox et al, 2014). Maternal
genetics and environmental exposure to a diverse outside microbiome are also incredibly
important for the development of a healthy and robust gut microbiome (Tiihonen et al, 2010;
Neggers, 2014). Maternal genetics influence fetal exposure in-vitro, during birth, through breast
milk, and through offspring genetics that can determine the development of a specific gut
bacterial profile. Additionally, the environment participates in the development of the immune
system, determines food diversity and other components that impact the digestive system and gut
response in a fetus or child (Lazar et al, 2018).
Microbiome-Gut-Brain Axis
The relationship between the microbiome, gut, and brain is called the Microbiome-GutBrain axis. It is an integrative system of communication that monitors and facilitates interrelated
changes. It connects the central nervous system to the enteric nervous system (Israelyan &
Margolis, 2018). The microorganisms that live in the gut are contained by a barrier consisting of
the microbiota, a mucous layer, and epithelial cells that are connected by regulatory gap
junctions that divide the cytoplasm of adjacent cells that allow for controlled molecule diffusion.
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In a healthy gut, nutrients and ions are allowed to pass through the tight junctions while toxins
and antigens are prevented from spreading through the body (Ulluwishewa et al, 2011).
The brain influences the enteric microbiota directly and indirectly. The autonomic
nervous system, which includes the sympathetic and parasympathetic nervous systems, mediates
communication between the CNS and the gut. The autonomic nervous system is responsible for
modulating gut functions that are vital to the survival of gut microbiota. Changes in villi motility,
secretion of bile and acid, bicarbonates, mucous, and intestinal immune response change the
intestinal environment and therefore directly impact microbiota's ability to survive, which can
change the profile and diversity of the bacteria present in the gut. For example, the majority of
bacteria live within the mucosal layer. Mucous secretion is controlled by the ANS. If the ANS
reduces mucous secretion then the gut's environment becomes less hospitable to anaerobic
bacteria, leading to a species shift that includes more facultative anaerobes. Stress responses that
are controlled by the ANS can also cause the gut to become more permeable and activate
immune responses that lead to decreases in microbial diversity (Rhee et al, 2009).
Bacteria can induce changes to physiology of the gut wall. Bifidobacterium bifidum and
Lactobacillus acidophilus are both able to promote gut motility, while Escherichia species can
inhibit gut motility affecting the host's nutritional uptake (Sang et al, 2009). Studies of germ-free
mice have shown that morphological consequences including enlarged cecums, reduced
intestinal surface area, increased enterochromaffin cell area, smaller Peyer's Patches and smaller
villous thickness are present in germ-free mice when compared to wild-type mice (Grenham et
al, 2011). Microbiota trigger toll-like receptors (TLRs) that maintain mucosal thickness and
stimulate repair the intestinal epithelial after injury. TLRs are critical for maintaining
inflammation response. A study done with mice that were deficient in TLR2, TLR4, and MyD88
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which is an adaptor molecule that is fundamental to TLR-mediated induction of inflammatory
cytokines showed that the deficient mice were significantly more likely to die when they were
treated with a toxin that kills colonic epithelium compared to wild type mice. No wild type mice
died while all of the TLR2, TLR4, and MyD88 deficient mice died. (Rakoff-Nahoum et al,
2004). Additionally, inflammation or stress increase intestinal permeability thus making it more
likely that microbial signaling molecules can interact with afferent nerve terminals or cause
signaling within the enterochromaffin cells, the transducer cells in the epithelial layer. More
specifically, cells in the gut secrete signaling peptides such as serotonin when triggered by
physiological or pathological luminal changes including changes in microbial factors or bacterial
toxins (Rhee et al, 2013).
Although serotonin is most well-known as a neurotransmitter in the brain, the majority of
serotonin is actually produced in the gut where it is synthesized from tryptophan, an essential
amino acid, by enterochromaffin cells and in neurons in the enteric nervous system (O’Mahony
et al, 2015 and Israelyan & Margolis, 2018). Interestingly, abnormalities in serotonin levels
during development can cause anatomical changes in the brain that result in delayed sensory map
formation (Muller et al, 2016). It has been hypothesized that serotonin is a key communicator
between the enteric nervous system and the central nervous system. It is critical for neuronal
differentiation and migration, axonal outgrowth, myelination, and synapse formation (Israelyan
& Margolis, 2018). Studies of germ-free mice have shown that without proper gut colonization
during early development, the central serotonergic system does not form properly. Gut bacteria,
especially lactic acid producing bacteria such as Lactobacillus johnsonii, influence tryptophan
availability and therefore serotonin synthesis. Lactobacilli that produce hydrogen peroxide can
inhibit enzymes important to synthesis (O'Mahony et al, 2015). Changes in the concentration of

13
intestinal metabolites produced by gut bacteria can increase serotonin levels without creating
more serotonin re-uptake transporters (SERT) (Israelyan & Margolis, 2018). When germ-free
mice are colonized by using microbes rich in Clostridium spp., serum and colon serotonin are
restored (Yano et a, 2016).
Thirty percent of individuals with ASD have high blood-serotonin levels and the high
levels correlate with symptoms of constipation (Marler et al, 2016). In polyinosinic:polycytidylic
acid (Poly(I:C)) mouse model experimentation, the Poly(I:C) mice expressed changes in
behavior, CNS development, intestinal permeability, and microbiome changes similar to patients
with ASD and that correlated with measured serotonin levels. (Israelyan & Margolis, 2018).
Poly(I:C) are a maternal immune-activation model. When there is maternal immune activation,
fetuses are exposed to pro-inflammatory cytokines that can disrupt brain development related
lead to ASD-like conditions (Reisinger et al, 2015). The Poly(I:C) models have been shown to
express increased levels of serotonin that accumulates without being properly broken down.
Neuroanatomical differences are present: the serotonin axons are blunted within the forebrain
(Goeden et al, 2016). Curiously, B. fragilis has shown some ability to regulate serotonin levels in
the Poly(I:C) mice and mitigate the ASD-like symptoms (Israelyan & Margolis, 2018).
The vagus nerve is the vital neuronal conduit between the microbiome and the central
nervous system. Vagal afferents can relay sensory information from the gastrointestinal system
and is a primary neural regulator of the gut. The interoceptive awareness of the vagal nerve
allows it to sense changes within the microbiome, convey the information from the enteric
nervous system to the central nervous system, integrate the information, and trigger a response
(Bonaz et al, 2018). Vagal afferent stimulation signals lower motor neurons in the brainstem that
signal other brain regions that are involved in physiological responses such as heart rate or
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cognitive responses that regulate the social engagement system. Social deficits are a defining
symptom of autism, while deregulation of the heartrate is a common comorbidity. It is
hypothesized that stereotyped behavior like rocking or swinging might be ways for people with
autism to regulate an inefficient vagal system by purposefully stimulating peripheral
baroreceptors that regulate blood pressure (Porges, 2005).
The vagal afferent fibers are found in every layer of the digestive wall except the
epithelium of the mucosa where bacteria live. Therefore, these fibers can respond to bacterial
products that can increase or decrease firing frequency of the vagus nerve. Serotonin and other
bacterial products in the gut such as short-chain fatty acids can activate the vagus nerve (Bonaz
et al, 2018). It is possible that unique bacterial species can influence human behavior via the
vagus nerve. Animal studies have shown that colonization of the gut with Lactobacillus reuteri
in Shank3B-/-, VPA, and BTBR mouse models which exhibit social deficits cause marked
improvement in social behavioral symptoms (Sgritta et al, 2019).
It is tempting to speculate that changes in either the gut, microbiome, or brain can result
in alterations to the downstream signaling pathways that display as ASD-related social behaviors
(Mayer et al, 2015). Epidemiology studies show that ASD children are more likely to have
gastrointestinal differences when compared to typically developing children. For example,
children with ASD have been shown to have significantly elevated numbers of Paneth's cells
which release antimicrobials in duodenal crypts (Horvath et al, 1999). Children with ASD are
more likely to have gut dysbiosis and less diverse microbiomes than typically developing agematched children (Li et al, 2017). They are also more likely to display gastrointestinal symptoms
like constipation, diarrhea, bloating, abdominal pain, reflux, vomiting, gaseousness, foul
smelling stools and food allergies than found in typically developing children (Fattorusso et al,
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2019 & Li et al, 2017). It is interesting to note that the severity of the gastrointestinal symptoms
is correlated with the severity of the ASD symptoms (Fattorusso et al, 2019).
The intestinal mucosa must be able to respond to constant challenges such as foreign
antigens, environmental microorganisms, antigens from digesting food, and pathogens. For
example, E. coli bacteria can invade intestinal cells, corrupt the immune response and tight
junctions, and compromise the intestinal barrier and increase intestinal permeability. Proper
regulation maintains mucosal immune function and prevents inflammation (Samsam et al, 2014).
The association in ASD between changes in the intestinal permeability and the worsening
regulatory potential of the gap junctions is referred to as the “leaky gut theory.” Inflammation,
especially chronic inflammation, of the gastrointestinal tract leads to weakening of the gap
junctions and increased permeability of the gut barrier. A higher percentage of intestinal
permeability has been recorded in children with autism compared to control children (Li et al,
2017). If the gut becomes more permeable, stress signals and metabolites from bacteria can
spread and penetrate the blood-brain barrier which protects the brain from environmental
dangers. The blood-brain- barrier and the gut-blood barrier show homology (Mahajan et al,
2019). Proper regulation maintains mucosal immune function and prevents inflammation
(Samsam et al, 2014). Inflammation of the gut-blood barrier due to inflammatory mediators can
lead to brain inflammation (Mahajan et al, 2019). Germ-free mice show elevated permeability in
their blood-brain-barriers (Braniste et al, 2014). An intact, well-functioning blood-brain-barrier
is critical for neurodevelopment.
Changes to the immune cells, including increased permeability, could cause systemic
changes. Mucosal immune cells within the intestines account for 70% of all the immune cells in
the body (Waslilewska & Klukowski, 2015). Specifically, bacterial products known as short
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chain fatty acids (SCFA) can induce localized inflammation to permeate through leaky guts to
eventually cross the blood brain barrier (Quigley, 2013; Dalile et al, 2019; Westfall et al, 2017;
van de Wouw et al, 2017). They can also induce specific changes in the brain such as the
activation of microglia. Dysbiosis or abnormalities of the gut microbiome and the subsequent
changes in intestinal permeability have been linked to changes in brain pathology (De Palma,
2014).
The largest percentages of short chain fatty acids produced in the human gut are acetate,
propionate, butyrate, isobutyrate, isovalerate, and valerate. Each of the short chain fatty acids is
capable of causing physiological changes in the human body. They are a major signaling
molecules produced by bacteria aiding in digestion (Morrison & Preston, 2016). SCFAs are
capable of modifying the colonic epithelial cells through phenotypic alteration, serving as major
energy sources, modulating the enteric neuroendocrine system, and functioning as inflammatory
factors (MacFabe, 2015). They are fundamental in balancing redox equivalent production in the
gut and maintaining homeostasis (den Besten et al, 2013). Poor diet, genetic disposition,
exposure to different bacteria in formative years, and competitive populating all contribute to
changing and maintaining proper bacterial ratios. Bacterial species changes will alter the short
chain fatty acid profiles and the physiological responses in populations (MacFabe, 2015).
SCFAs have been shown to be immunomodulatory. They are signals for G-protein
coupled receptors that activate signaling cascades, controlling inflammation, and have been
linked to inflammatory diseases like inflammatory bowel disease, ulcerative colitis, and Crohn's
Disease which are all characterized by chronic gastrointestinal inflammation. Children with ASD
are significantly more likely than children without ASD to suffer from gastrointestinal distress
and chronic bowel inflammation (Waslilewska & Klukowski, 2015). The SCFA butyrate is most
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closely linked to being anti-inflammatory (Venegas et al, 2019). Butyrate is also capable of
altering the activity of cells within the blood-brain-barrier, which controls what can substances
cross into the brain and has been linked to major depressive disorders (Huang et al, 2019).
Likewise, in animal models that have been treated with propionate, the animals begin to show
behavioral abnormalities similar to what is expected with ASD (Choi et al, 2018).
Several studies have identified that the bacterial profiles of autistic children are different
from typically developing children. Clostridiales, Betaproteobacteria, and Lactobacillus are all
higher in proportion in the ASD microbiome (Srikantha & Mohajeri, 2019). In a 2005 study,
experimentation showed that autistic children were more likely to have toxin-producing
Clostridium subtypes that can cause gut disfunction when compared to their siblings (Parracho et
al, 2005). Late-onset autistic patients that were treated with the antibiotic vancomycin
demonstrated an improvement in behavioral and gastrointestinal symptoms that was associated
with a reduction of the toxin-producing Clostridium bacterial species in those patients; however,
the symptoms returned upon stopping the medication (Finegold et al, 2002). Sutterella and
Desulfovibrio populations tend also to be disproportionately larger in ASD populations (Benach
et al, 2012). It is unknown what role these differences might play in the etiology of ASD, but it is
suggestive that gut microbiota might be useful as a marker and lead to subsequent studies of
downstream inflammatory events (Midtvedt, 2012). Interestingly, the severity of overall changes
in the microbiota are correlated with the severity of the location of the patient on the spectrum of
the disorder (Vuong & Hsiao, 2017).
Microbes colonize sections of the digestive tract differently. In the small intestine, food
digestion and absorption of nutrients occurs. The small intestine can be subdivided into three
main parts: the duodenum where food chime enters from the stomach, and the jejunum which is
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characterized by muscular flaps called “plicae circulares” and villi that aid in absorption of
digested food, and ilium that absorbs nutrients including bile acids and B12. The ileum connects
to the large intestine (Collins & Badireddy, 2019). The large intestine is responsible for water
and mineral absorption and can be subdivided into four sections: the ascending colon with the
cecum, transverse colon, descending colon, and sigmoid colon. Complex foods that cannot be
digested by the human gut may be digested by the microbes that the intestines host (Hillman et
al, 2017). Stomach acidity, bile and gastric acid, and peristalsis likely result in fewer bacteria
colonizing the proximal small intestines. More microbes, with a shift from aerobic to anaerobic,
can be found as the body progresses from the small intestines to large intestines (Quigley, 2013).
Anatomically, the small intestine sections can be identified by a glandular layer. The duodenum
is characterized by the presence of Brunner's glands, the jejunum has varying glands and larger
numbers of lymph nodes, and the ileum is characterized by the presence of Peyer's glands (Kim
et al, 2013).
The wall of the gastrointestinal tract can be subdivided into four main layers: the tunica
mucosa, tunica submucosa, tunica muscularis, and serosa or adventitia. Atrophy and
inflammation are common in gastrointestinal disorders like Celiac disease, which is positively
associated with ASD (Ludvigsson et al, 2013). The tunica mucosa lines the lumen and serves to
protect the small intestine from contamination from the gut microbiome and antigens and
pathogens from the external environment. It also is responsible for secretion and absorption
during digestion. The tunica submucosa is highly vascularized and contains the submucosal
nerve plexus and glandular tissue. Vagal villi afferents terminate in the villus, while vagal crypt
afferent endings encircle the luminal end of crypts. The mucosal afferents can detect stretching
and tension, as well as chemical absorption and transmit the information to the CNS. The
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afferents are sensitive to bacterially produced short-chain fatty acids as well as cytokines,
nutrients, and hormones, allowing for bacteria to effect change on the gastrointestinal system
(Fülling et al, 2019). The submucosal nerve plexus is largely responsible for controlling
glandular secretion. The tunica muscularis is made of two layers of smooth muscles with the
myenteric nerve plexus in between the muscular layers. The myenteric nerve plexus is
responsible mainly for motility. Within the muscular layer, vagal afferents form intraganglionic
laminar endings and intramuscular arrays and synapse onto neurons from the ENS (Fülling et al,
2019). The tunica serosa covers organs in the peritoneal cavity (Nováková & Blanková, 2018).
Mouse Models
Mouse models can help show insight into the pathophysiology behind ASD symptoms.
Mice are very social creatures that can exhibit social behavioral deficits and have homologous
digestive tract anatomy with humans so that they can be used in studies. The following study
compared intestinal samples from wild-type control mice, C57BL/6J, to mice with social
behavioral deficits including the BTBR genetic knockouts, valproic acid injected C57BL/6J, and
polycytidylic acid injected C57BL/6J mice.
C57BL/6J mice are commonly used as control mice in ASD studies. The mice
demonstrate extreme genetically similarity between individuals (Song & Hwang, 2017).
Compared to other inbred mice groups, C57BL/6J mice show good ability for complex learning,
including testing for contextualized fear conditioning. In prepulse testing, in which a loud noise
triggers the mice's startle reflex and the mouse, these animals can become desensitized to the
noise to demonstrate a lower prepulse inhibition than other inbred strains (Crawley et al, 1997).
They are highly social, as measured in Social Approach Tests. However, sociability scores
change throughout their development, with sociability being variable in male mice more so than
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female mice during puberty around days 25 to 45 of life. The changing of behavior during
development mirrors the progression of ASD. Similarly, larger litters and litters with more
female mice showed increased sociability. The sociability link with high female to male ratios
demonstrates that prenatal hormonal exposure could be a variant in sociability. Likewise, male
mice who gestate next to female mice are exposed to more estradiol and less testosterone than
male mice who develop next to male mice. The hormone-gestation link is similar to the
hypothesis that exposure to high prenatal testosterone makes it more likely that an individual
may develop ASD (Fairless et al, 2012).
BTBR genetic knockout mice have been used for studies of autism-like behaviors
including reduced social interactions, impaired play, unusual vocalizations, and repetitive
behaviors such as obsessive self-grooming that causes balding. They are known for having a
markedly reduced or absent corpus callosum and impaired synaptogenesis and neurogenesis
(Meyza et al, 2013). They have reduced social motivation processes and do not form conditioned
place preferences for contexts related to social stimuli and may be due to problems with retention
of memory of social-specific cues (Careaga et al, 2015). Neuroanatomical similarities have been
noted between the BTBR mice and subpopulations of ASD patients such as the changes in the
hippocampus and amygdala shape and location, the presence of Probst bundles that fail to cross
the corpus callosum, and the distance between ventricles. BTBR mice have marked
sensorimotor balance difficulties. Studies have shown that administering ketogenic diets can
restore sensorimotor skills and improve sociability implicating the gut. Administering serotonin
(5HT) agonists to these mice has been shown to increase the mice's social approach possibly
implicating the gut. BTBR mice have an altered stress response and tend to show more anxiety
than other inbred mice groups. Additionally, they are known to have gut dysbiosis similar to that

21
of patients with ASD and increased gut permeability in the large intestine. The dysbiosis is
different between male and female mice, just ASD presents differently in male and female
patients (Coretti et al, 2017).
The valproic acid model is created by injecting pregnant C57BL/6J dams at gestational
day 11 with valproic acid. Valproic acid is a long-standing drug for epilepsy and a mood
stabilizer (Bath & Pimentel, 2017). It is known to have gastrointestinal side effects (Jahromi et
al, 2011). In the United States, it is prescribed to around 22% of children with epilepsy.
Children who take the drug during adolescence are more likely to have problems with cognitive
functioning and lower IQ scores and reduced motor performance and visuospatial functioning
(Bath & Pimentel, 2017). During gestation, if a pregnant mother takes valproic acid, there is
increased incidence of ASD for the children. Pups who were prenatally exposed to valproic acid
also show social behavioral deficits. They have been shown to have developmental delays in
self-righting, eye opening tests, and impaired social recognition (Yang et al, 2016). The mice
also show gut dysbiosis between males and females. Valproic-acid exposed males show
significantly higher levels of Bacteroidetes when compared to wild-type control male mice (Liu
et al, 2018). Rats prenatally exposed to valproic acid show decreased gastrointestinal mobility
and decreased thickness of tunica mucosa and tunica muscularis in the stomach, duodenum,
jejunum, ileum, and colon (Kim et al, 2013).
The maternal immune activated model consists of pregnant C57BL/6J dams injected with
polycytidylic acid (Poly I:C) at gestational day 11. Maternal immune activation can increase the
severity of ASD-like symptoms, increasing the number of ultrasonic calls in young pups and
marble burying tendencies (Meyza & Blanchard, 2017). The immune activation causes
inflammatory response that results in social behavior deficits (Chow et al, 2016). Poly(I:C) is a
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synthetic analogue of double-stranded RNA that is similar to molecules synthesized during viral
replication. The severity of the long-term brain and behavioral changes are positively correlated
with the intensity of the immune reaction and inflammation response caused by the Poly I:C
(Meyer, 2014). Poly(I:C) pups show delays in growth and sensorimotor development. They have
delays in righting ability, geotaxis, and problematic grasping reflexes (Arsenault et al, 2014).
They show reduced social interaction and decreased memory and learning ability in juveniles.
Male Poly(I:C) mice are more likely to have reduced desire to interact with novel mice than
female mice and the behavioral qualities show sooner, just as with ASD (Ratnayake et al, 2014).
Neuroinflammatory responses and increased cytokine levels suggest brain inflammation from an
early age, which could explain the complications in neurodevelopment and the developmental
delays (Arsenault et al, 2014). There are few studies involving the gut microbiome in Poly (I:C)
mice, but there is evidence that acute exposure to Poly(I:C) after birth reduces colon
permeability to macromolecules but increases ileum permeability to electrolytes and small
molecules (Moyano-Porcile et al, 2015). Unfortunately, the current Poly(I:C) analogues
available on the market are unstable and can result in variable responses in the animals.
Hypothesis
The following study is crucial in identifying gastrointestinal markers in mouse models of
social behavioral deficits, a core symptom of ASD. The gut-brain-microbiota axis is
bidirectional and dependent on bacterial colonization and short chain fatty acid production that
can impact the digestive tract physiology. It is expected that each mouse will demonstrate a
unique SCFA profile. Additionally, it is hypothesized that significant morphological differences
will exist in one or all of the different mouse groups when compared to wild-type control mice.
Specifically, it is expected that the tunica muscularis and tunica mucosa will be significantly
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different in the BTBR genetic knockouts, valproic acid model, or polycytidylic acid model when
compared to wild-type control mice.

24
METHODS
Animal Care
All experiments that used animals were approved by the University Committee on
Animal Care at East Tennessee State University. Animals were housed in plastic cages in a
standard 12-hour light and dark cycle with unlimited access to food and water. The mouse strain,
C57BL/6J, was obtained from Jaxson Laboratories. C57BL/6J mice were bred in the ETSU
animal facility and reared in the same conditions. Pregnant C57BL/6J female dams were either
given intraperitoneal injections of valproic acid 600 mg/kg (PXXXX, Sigma, St. Louis, MO) or
with polycytidylic acid (PXXXX, Sigma, St. Louis, MO) 5mg/kg dissolved in 0.9% sodium
chloride solution at gestational day eleven. Pups were reared until postnatal day 21 (P21) or
postnatal day 105 (P105). The genetic inbred strain, BTBRT+Itpr3tf/J (BTBR), mice were
obtained from Jaxson labs and reared on site in the same conditions for experimentation. Only
male mice were used in the experimental studies.

Marble Burying
Marble burying was performed to test for repetitive behaviors in the mice. Rat cages were
filled with 2 to 3 inches of bedding. A clear lid was placed on each of the cages. Mice were put
in individual cages for 20 minutes in the dark in order to acclimate to testing conditions. Mice
were removed and twenty marbles were placed in five symmetrical rows. The mice were
returned to the cages with marbles for 20 minutes. The mice were then removed and then the
number of marbles buried was counted. A marble was counted as buried if it was more than 2/3
concealed under the bedding. Three independent counters were used, and the median count was
calculated for each mouse.
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Social Testing
The sociability test was performed using a box with three chambers of identical size with
openings into each chamber. A small wire cage is placed in chambers one and three. Mice were
habituated with free movement for an initial five-minute period in which the test mouse was
allowed to roam while both of the interior cages were empty. In the second phase, one familiar
mouse was placed into an interior cage and the test mouse was allowed to roam. In the third
phase, an unfamiliar mouse was placed in the remaining interior cage and the test mouse was
allowed to roam. Each phase was video recorded and time spent in each chamber was calculated
using Anymaze tracking software.

Fecal Collection
Fecal samples were collected at approximately P105 for the adult male mice. Mice were
placed in sterile, bed-free cages for thirty-five minutes. Initially, the abdomen of the mouse was
massaged and the mouse was lifted by the tail to encourage defecation. Feces was collected in
pre-weighed 1.5 ml Eppendorf tubes. Fecal mass was determined and stored at -80°C until use.
Approximately 2 mg of feces was collected for each mouse.

Short-Chain Fatty Acid Assay
The SCFA extraction procedures were modeled after research done by Schwiertz et al
and modified. One milliliter of the SCFA solution, which contained oxalic acid (0.1 mol/L),
sodium azide (40 mmol/L), and caproic acid (0.1 mmol/L) was added to approximately 450
milligrams (wet-weight) or 80 mg (dry-weight) of feces that had been freeze-dried and stored -
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81°C in a 16 x 100 mm disposable culture tube. Samples were vortexed for 30 seconds and
placed on a horizontal shaker for one hour. After the incubation, samples were centrifuged for
twenty minutes at 4000 revolutions per minute or rpms. The supernatant was removed and
placed in a 1.5 mL polypropylene micro-centrifuge tube. Solution was followed with a
centrifugation step at 12,000 rpm for 15 minutes. The supernatant was removed and put into a 2
mL amber vial to be stored at -81°C until it was analyzed with a Shimandzu GC2010 gas
chromatograph with a Sigma-Aldrich ZB-Wax Plus capillary column. The samples were run
using the SCFA.standard.run.gcm method.

Statistical Analysis of Short Chain Fatty Acid Data
Statistical Analysis was done using an ANOVA: One-Factor Without Replication test to
compare the average grams of acetate, propionate, isobutyrate, butyrate, isovalerate, and valerate
per 80 milligrams of sample in the wildtype group compared to the valproic acid, BTBR, and
Poly(I:C) behavior models. Dunnett’s multiple comparison’s test was used as a post-hoc test.
The calculated p-values were considered significant <0.05.

Intestinal Preparation
At P21 or P105 days, mouse small and large intestines were obtained and put into 4%
paraformaldehyde. After 24 hours, the intestines were washed with 70% ethanol and stored at
4oC until embedding. In brief, samples of the ileum were then embedded in wax, sectioned, and
prepared for staining. Ileum sections were placed into 0.5 cm samples in length and placing the
section tissue into metal cages for dehydration. Dehydration was done by placing the cages in
80% ethanol, 90% ethanol, and 95% ethanol in order for 30 minutes per solution. The cages were
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then soaked in 100% ethanol for 30 minutes twice. The cages were then placed in 50:50 100%
ethanol:Citrisolv concentrate for 30 minutes. Next, the cages were placed in 100% Citrisolv for
30 minutes. Following steps included incubating tissues in two changes of Paraplast embedding
medium for one hour each. Finally, the tissue was embedded in fresh Paraplast vertically to
allow for cross sectioning and stored at room temperature.

Hematoxylin and Eosin Staining
Previously prepared hematoxylin was filtered through a coffee-filter filtration system to
remove impurities. The slides were simultaneously placed in different solutions using a strict
time regimen. The first phase was rehydration. Slides with tissue were placed in hemo-de 1,
hemo-de 2, 100% ETOH, 100% ETOH, 95% ETOH, 80 % ETOH, and 75% ETOH for three
minutes each. The slides were then rinsed in distilled water for two minutes three times. Once
rinsed, the slides were incubated in the hematoxylin for exactly three minutes, washed in distilled
water for five minutes, and then dipped in 0.3% acid alcohol 8-12 times. Afterwards, the slides
were washed for one minute twice in tap water and then for two minutes in distilled water. Once
rinsed, the slides were placed in eosin for 30-45 seconds. During the dehydration phase, the
soaking steps from the rehydration phase were repeated but in reverse, except that the ethanol
steps were timed for 2 minutes each. The two hematotoxin soaks were performed for 3 minutes
each. The slides were left to dry for at least 24 hours, and then covered with a coverslip using
permount and left to dry for at least another 24 hours.

28

Image Acquisition and Tissue Measurements
Using a Zeiss Axioskop 40 microscope with a Cannon Powershot A640 camera, sections
of ileum from each model were taken at 10X magnification. The samples were confirmed to be
ileum using standardized image comparison to available ileum tissue. The thickness of the tunica
muscularis and tunica mucosa were measured using standardized measuring scaling of pixels/nm
from the Axios software. The tunica mucosa was measured from the bottom of the glandular
tissue to the top of the villi six times per sample in equal intervals given that the tissue layers
were clearly defined and had not been stripped during staining. The tunica muscularis excluded
the submucosa in all measurements. Tunica muscularis measurements were only taken if the
tissue was fully intact and not in ribbons. Tissue samples were excluded if the tunica muscularis
or tunica mucosa were not clearly intact.

Statistical Analysis of Tissue Measurements
The tunica mucosa and tunica muscularis thicknesses in the mouse models of social
deficits for P21 and P105 were compared to the wild type at P21 and P105 accordingly. A oneway ANOVA with Bonferroni post-hoc test with calculated significance of p<0.05 was used.
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RESULTS
Behavioral Studies
Sociability testing and marble burying measurements were used to confirm that the
mouse models of social deficits were showing the expected social deficits. Figure 1 shows that
both polycytidylic acid injected C57BL/6J offspring and wild type mice were more likely to
prefer empty cages than cages with familiar mice. Valproic acid injected C57BL/6J offspring
mice and BTBR genetic knockout mice did not show a preference in choosing to interact with a
mouse over an object. A p-value of <0.05 was considered significant.

Figure 1. Sociability of Mouse Models of Social Behavior. Mice were evaluated for time spent
with novel object or live animal with “duration” referring to the average time. Significant
differences with p-values<0.05 are denoted by asterisks (Wild type N=6, Valproic acid N=10,
BTBR N=9, and Poly(I:C) Males: N=8).
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A second measure of behavior was performed to assess for repetitive behaviors in the
animals. Repetitive behaviors must be displayed for an ASD diagnosis in human patients. The
marble burying assay is used as a measure of mouse behavior when the animal is presented with
multiple, novel objects in a novel environment. Our findings demonstrate that the wild type
mice were significantly more likely to bury more marbles than the valproic acid injected
C57BL/6J offspring and BTBR genetic knockout mice. BTBR genetic knockout mice were more
likely to bury more marbles than valproic acid injected C57BL/6J offspring, although it was not
statistically significant. Figure 2 shows the overall average number of marbles buried by each
male group and the significance. There were no significant differences between the
polycytidylic acid inject C57BL/6J mice and any other group. The numbers of marbles buried by
each group is shown in Charts 1-8 in the Appendix. A p-value of <0.05 was considered
significant.

Figure 2. Marble Burying Assay of Mouse Models of Social Behavior. Mice were evaluated
for repetitive behaviors with “No. of Marbles Buried” referring to the number of marbles that
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were at least 2/3 buried. Significance is denoted by p-values of ** <0.01 and ***<.0001(control
N=6, VA Males N=7, BTBR Males N=8, Poly(I:C) Males N=8).

Short Chain Fatty Acid Assays
Short-chain fatty assays were performed on the fecal samples to determine profile
differences between the mouse models of social behavioral deficits. Table-1 shows the results of
an ANOVA one- way statistical analysis comparing all mouse groups. P-values less than 0.05 are
considered significant. Significant p-values are shown with asterisks: *denotes p<0.05,
**denotes that p<0.01, and *** denotes that p<0.001. Offspring from valproic acid injected
C57BL/6J mice and BTBR genetic knockout mice have significantly different levels of acetate,
propionate, isobutyrate, butyrate, and valerate in their short-chain fatty acid profiles when
compared to wild-type control mice. The polycytidylic acid injected C57BL/6J offspring did not
have any measured significant differences compared to the control mice. It should be noted that
only two animals were used in the polycytidylic acid injected C57BL/6J offspring group. Lastly,
isovalerate levels were not significantly different in any of the groups compared to the wild type
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Significance levels in SCFA per 80 mg of the Sample
SCFA (% Area Under
Wild Type vs
Wild Type vs
Wild Type vs Poly
the Curve)
Valproic Acid pBTBR
I:C P-Value
value
p-value
Acetate
* 0.0007
** 0.0038
0.7954
Propionate

Isobutyrate
Butyrate
Isovalerate
Valerate

*** <0.0001

*** <0.0001

** 0.0023

* 0.0174

** 0.0042

* 0.0123

0.5957

0.9792

** 0.0044

* 0.0133

0.4253
0.2801
0.9429
0.9244
0.2321

Table 1. Significance Levels in SCFA per 80 mg of Sample in Mouse Models of Social
Behavior (C57BL/6J males: N=6, VA males: N=7, BTBR males: N=8, Poly(I:C) males: N=2).

Levels of SCFA in graph form are from ach group are shown in Figures 4 and 5. Short
chain fatty acids that were measured included: acetate, propionate, isobutyrate, butyrate,
isovalerate, and valerate (Figure 4). They are the most common SCFA that are expressed in
mice. Acetate is shown independently due to the disproportionately larger amounts of this SCFA
as compared to the other SCFA levels in mice (Figure 5). All SCFA data are shown in the
Appendix Supplemental Table 9.
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Average mg Acetate per 80 mg of Sample in Mouse
Models of Social Deficits

Milligrams of Acetate

12
10
8

**

**

6
4
2
0
Wild Type

Valproic Acid

BTBR

Poly(I:C)

Short-Chain Fatty Acid Profiles
Wild Type

Valproic Acid

BTBR

Poly(I:C)

Figure 4. Average milligrams of acetate per 80 milligrams of sample in mouse models of social
deficits (C57BL/6J males: N=6, VA males: N=7, BTBR males: N=8, Poly(I:C) males: N=2).
Significance is denoted by p-values** <0.01.
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Average mg SCFA per 80 mg of Sample in Mouse Models
of Social Deficits

Milligrams of SCFA

2.5
2
1.5

**

**

** **

1
0.5

** **

** **

0
Propionate

Isobutyrate

Butyrate

Isovalerate

Valerate

Short-Chain Fatty Acid Profiles
Wild Type

Valproic Acid

BTBR

Poly(I:C)

Figure 5. Average milligrams of propionate, isobutyrate, butyrate, isovalerate, and valerate per
80 milligrams of sample in mouse models of social behavioral deficits (C57BL/6J males: N=6,
VA males: N=7, BTBR males: N=8, Poly(I:C) males: N=2). Significance is denoted by pvalues** <0.01.

Intestinal Morphology Measurements
The lengths of the tunica muscularis and tunica mucosa were measured in postnatal day
21 (P21) and postnatal day 105 (P105) mice in order to show if there was a significant difference
in the measured thickness between the wild type and the mouse models of social behavioral
deficits. Figure 6 demonstrates the length of the tunica muscularis in mice from the wild type
group as compared to the mouse models of social deficits at P21, and Figure 7 demonstrates the
lengths of the tunica muscularis at P105. Valproic acid injected offspring were significantly
different than control mice (p=0.0463) at P21. A p-value of <0.05 was considered significant. At
postnatal day 105, the tunica muscularis appeared to be trending toward a reduction but was not
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significantly different between any the groups. Overall, it was noted that the tunica layers were
longer in the adult group than in the immature group. Figures 8 and 9 compare the lengths of the
tunica mucosa of the wild type mice compared to the mouse models of social deficits at P21 and
P105 accordingly. Reductions in the tunica mucosa length in the valproic acid group when
compared to wild type control mice were significantly different (p=0.0279) in the 21-day old
group (Figure 8). For the 105-day old group, no significant differences were not found when
comparing groups (Figure 9). It should be noted that only one valproic acid gave reliable results;
therefore, more animals will have to be used in the future to obtain official results. For Figures 6
through 9, the mice used for imaging are listed in Appendix Supplemental Table 10. Images
used for measurements for each animal can be seen in the Appendix Supplemental Images 1-8.
The different ages are representative of an immature mouse at P21 days and a fully developed
adult mouse at P105 days. A one-way ANOVA was used to measure differences between
groups.
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Figure 6. Length of the tunica muscularis in uM at 21 days of development in mouse models of
social deficits. Dots denote the number of animals used in the study (Wild type N=6, BTBR
N=4, Valproic Acid N=6, and Poly IC N=2). Significance is denoted with asterisks* using a
one-way ANOVA with p-values of <0.05.
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Figure 7. Length of the tunica muscularis in uM at 105 days of development in mouse models of
social deficits. Dots denote the number of animals used in the study (Wild type N=2, BTBR
N=4, Valproic Acid N=1, and Poly IC N=3). Significance was not observed using a one-way
ANOVA with p-values of <0.05.

38

Figure 8. Length of the tunica mucosa in uM at 21 days of development in mouse models of
social deficits. Dots denote the number of animals used in the study (Wild type N=5, BTBR
N=2, Valproic Acid N=6, and Poly IC N=2). Significance using a one-way ANOVA is denoted
with asterisks* of p-values of <0.05.
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Figure 9. Length of the tunica mucosa in uM at 105 days of development in mouse models of
social deficits. Dots denote the number of animals used in the study (Wild type N=2, BTBR
N=4, Valproic Acid N=1, and Poly IC N=3). Significance was not observed using a one-way
ANOVA with p-values of <0.05.
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DISCUSSION
Behavioral Studies
There is currently no accepted animal model for autism spectrum disorder, but there are
many models that display independent features. The behavioral studies were performed to
ensure that the mice used in the studies demonstrated behaviors that have been identified in
previous studies for these particular models. The results did support that the mice exhibited
social behavioral deficits using the sociability test. However, the marble burying test for
repetitive behaviors displayed conflicting results when compared to the literature. The marble
burying test for the symptomatic increase in anxiety and repetitive behavior is associated with
ASD. Mice show “defensive burying” when stressed, and therefore it is believed that mice with
unregulated anxiety who are prone to more repetitive behaviors will bury more marbles.
Research done by Thomas et al suggests that marble burying may not be indicative of novelty
anxiety inasmuch as genetic predisposition for repetitive behavior. Therefore, it was expected
that the wildtype group would bury the smallest amount of marbles. The results in this study
showed the opposite with control mice burying the largest number of marbles. It is likely that the
results were confounded by differences in the mice’s burying and scurrying techniques, as even
though the number of marbles buried was unexpected, the mice showed different behaviors
during the trials. Additionally, rater behavior may have been different for the control group. The
number of people who counted marbles and the number of marbles counted for each mouse is
shown in supplemental tables 1-8 in the appendix. It was found that two of the three raters for
the wild type control mice had elevated numbers when compared to a third rater. Marbles were
only to be counted if they were two thirds buried in bedding. Mice burying the marbles were
video recorded to determine if differences in their burying behavior could be identified by

41
viewing the animals. Burying behavior was different among the groups. For example, BTBR
mice showed more active burying but fewer marbles, while C57 mice were more likely to dig in
the corners of the cages with marbles then falling into holes as a consequence of the techniques.
Additionally, there was variation among the individual counters who counted if the marbles were
2/3 buried or not, which can be seen in the Appendix. These studies will be repeated in the
future.

Although in the wrong direction, it is observed that the wild type control mice and the

Poly(I:C) mice are significantly different from the valproic acid injected offspring and the BTBR
mice. It should be noted that the Poly (I:C) mice had a very small study number, and given that
the Poly(I:C) group’s data was continually similar to the wildtype group, then it is highly likely
that the dams did not receive the correct ratio of long versus short polyinosinic–polycytidylic
acid molecules that are required for animals to display behavior.
A defining characteristic of autism spectrum disorders is an aversion to interacting with
other people. It was expected in the sociability test that the wildtype mice would show more
curiosity towards the cage with a mouse in it than towards an inanimate object while the social
deficit mice would not show any inclination towards the house mouse with whom they were
familiar or would prefer the inanimate cage (Moy et al, 2004) The mice in these studies simply
did not have a preference. It has been noted that a confounding variable may exist in the social
testing. For example, testing by Pearson et al showed that C57BL/6J mice may fail to exhibit
social novelty in non-novel situations, meaning if the mice have acclimated to the three-chamber
maze, then they will not show preference. The mice these studies may have been acclimated too
early, especially because they were used as house mice before they were tested for novelty in
some situations. It should be noted that the models used in these studies are highly reliable in
demonstrating the social behaviors in the literature and coupled with differences among the
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marble burying raters it appears they are valid study animals. Also, the valproic injected
pregnant dams would demonstrate loss of consciousness after the valproic acid injection
indicating that they did receive the required dose.
Despite the lack of robust behavioral results, it is still likely that the models still are
reliable representations of ASD because of their historical use and the display of behavioral
differences after injection. In the future, the trials should be repeated with several changes. For
sociability testing, more consideration should be given to ensuring that the maze remains novel
for the mice. Additionally, more specific measures i.e. time that mice are in the center around the
object or the time in corner may be analyzed rather than just simply chamber time. As for
marble burying, the same raters should be used for all trials to demonstrate consistency in
determining the marble depth buried and the mice should always be video recorded so that
unusual behavior can be better measured.

Short Chain Fatty Acid Assays
It was hypothesized that each mouse group would have a unique SCFA profile. This was
supported by the significant differences in acetate, propionate, butyrate, and valerate amounts in
feces from wild type controls and mice with social behavioral deficits. There were no significant
differences in the amounts of isovalerate. Given that bacteria are what are producing the SCFA,
the data suggests different bacterial profiles are different in the social deficit groups. Acetate is
utilized to prevent enteropathogenic infection which can harm gut integrity; therefore, lower
levels of acetate in the valproic acid and BTBR models may be indicative of a weakening
intestinal barrier and increasing exposure of the vagal afferents (Fukuda et al, 2011). Acetate is
used by bacteria in the synthesis of butyrate, which could be a factor in the lower amounts of
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butyrate (Skonieczna-Żydecka et al, 2018). Likewise, butyrate has also been cited as having an
important role in maintaining barrier integrity the small intestine (Chambers et al, 2018),
regulating transepithelial fluid transport, preventing or managing mucosal inflammation and
oxidative stress, and modulating visceral sensitivity and intestinal motility (Canani et al, 2011).
Propionate, which was seen in lower levels in the valproic acid and BTBR groups, modulates
immune response in the gut by reducing the cytokine load and stimulates Bifidobacterium which
can aid in restoring proper gut permeability (Skonieczna-Żydecka et al, 2018). Like valerate,
which is not well studied, accumulation or overexposure to propionate can lead to developmental
delay and gastrointestinal disorders (Nankova et al, 2014) There was no significant difference in
isovalerate levels. Very little research has been done on isovalerate (Stieb & Schink, 1986) and
further study of it to see why the levels remain the same could be done.
The mouse data collected is concurrent with previous findings in humans with ASD that
there are fewer SCFA produced overall. There are significantly reduced amounts of acetate,
butyrate, propionate, and valerate in human fecal matter in patients with ASD compared to those
without ASD with a 27% reduction of SCFA overall (Adams et al, 2011). Interestingly, some
human studies have shown that there is an increase in valerate in human populations with ASD
(Liu et al, 2019). Additionally, the valproic acid and BTBR groups have profiles more similar to
each other than the wildtype, supporting that while there is a range of profiles between different
severities of ASD, ASD groups are more similar to each other than non-ASD comparisons.
Human data can be plagued with biased results due to an individual’s diet; but the same diet was
used in these mouse studies. Additionally, the valproic acid and poly IC offspring came from a
wild-type dam.
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Intestinal Morphology
The intestinal morphology data did not demonstrate robust significant differences
between the wild type control mice and the mice with social behavior deficits. It must be noted
that extremely small samples were eventually investigated. Offspring from the valproic acid
treated dam did show significant differences in the lengths of the tunica muscularis and tunica
mucosa for P21. Future studies could include exploration of the intestinal morphology
relationship to vagus nerve stimulation. The tunica mucosa protects the underlying submucosal
nerve plexus from toxic short-chain fatty acid products and bacterial toxins that ultimately
weaken the intestinal barrier. The valproic acid model showed evidence of dysbiosis in the shortchain fatty acid expression and irregular patterns of SCFA signaling molecules. Changes in the
intestinal barrier could amplify the effects of the dysbiosis making the vagal afferents more apt
to generate an action potential. Vagal sensitivity is thought to be a common symptom of ASD.
Additionally, the tunica muscularis contains the intrinsic myenteric nerve plexus that controls
intestinal motility. Damage to the myenteric plexus can cause other gastrointestinal issues
demonstrating a possible relationship to the gastrointestinal comorbidities associated with ASD.
The BTBR group did not show significant differences in the sizes of the tunica
muscularis or tunica mucosa. The tunica mucosa and tunica muscularis were smaller, but not
significantly different. More samples are needed to make a definitive conclusion. It is possible
that the differences between the valproic acid and BTBR mice may be representative of the ASD
spectrum. For example, not all patients with ASD exhibit gastrointestinal symptoms or serotonin
dysregulation from improper gut functioning. Therefore, changes in intestinal morphology may
be part of a subgroup of ASD presentations. The identification of subpopulations with similar
pathophysiology is a major need in ASD research.
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Limitations
Limitations of this experimentation were likely present. It is highly likely that the
Poly(I:C) models were not successfully injected and were more similar to C57BL/6J than to the
behavioral deficit model that they were supposed to represent. The sample size for Poly(I:C)
was only 2 for both behavioral and SCFA assay testing, so it needs to be increased in future
studies. We opted to discontinue the Poly(I:C) studies until a better chemical is available but
wanted to show the data due to the similarity to the control group. Additionally, the wildtype
possessed an outlier in aggression (supplemental table 1). The mouse was removed prior to the
study and was not included in any part of the study.
During the intestine morphology study, there were issues with the tissue being properly
embedded and some tissue samples were stripped or destroyed reducing sample sizes and
making it more difficult to ascertain results from some samples. In future trials, it is
recommended that only the ileum near the cecum is used for the necessity of having an
anatomical landmark due to the difficulty of differentiating the duodenum, jejunum, and ileum.
Future studies may look into the large intestine due to its continuing, more reliable anatomy.
Sample size will need to be increased prior to publication.

Conclusions
The microbiome-gut-brain axis is an integrative system of communication that monitors
and facilitates interrelated changes. It connects the central nervous system to the enteric nervous
system. These studies identified differences in SCFA production in the gut of mouse models of
social behavior deficits. Short-chain fatty acid profile differences due to dysbiosis in the
microbiome likely causes altered signaling patterns which negatively impact intestinal
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morphology and signaling to the brain. The vagus nerve serves as the pathway connecting the
enteric nervous system to the central nervous system. Exposed vagal nerve afferents and increase
intestinal permeability facilitate systematic changes. In ASD, the changes could exacerbate
behavioral symptoms and gastrointestinal distress. The gut microbiome and intestinal
morphology are both affected by genetics and the environment. Using mouse models of social
deficits, it become apparent that the microbiome is fundamental to health. Future research should
look at gut dysbiosis, short-chain fatty acid profiles, and intestinal morphology in mouse models
to elucidate serotonin influences on the production in the gut that facilitate change in the brains.
The prevalence of dysbiosis and altered signaling pathways in mouse models point to possible
therapeutics for ASD treatment in human patients to alleviate gastrointestinal distress,
overwhelmed vagal systems, and negative behavioral patterns.
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APPENDIX
C57BL/6J
Marble
Burying
Performed
10-18-18
Researcher 1 Researcher 2 Researcher 3 Average
Group 1
M0

7

5

4

5.3

M1

10

9

7

8.7

M2

12

11

18

13.7

******Group
2 was housed
Group 2

with violent
mouse. Mice
had wounded
tails.

M3

17

14

16

15.7

M4

10

12

12

11.3

M5

15

18

12

15

Total
Average:

11.6

Supplemental Table 1. Marbles buried during marble burying protocol by Group 1 and 2 of
male C57BL/6J mice. Three independent researchers were trained on marble burying protocol
and asked to count the number of marbles buried once the mice had been removed from the
testing enclosures. Group 2 was housed with an unusually violent mouse that was removed and
not included in the study. The remaining mice had wounded tails.
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C57BL/6J
Marble
Burying
Performed
10-20-18

Group 3

Researcher
1
Trial 1
Trail 2

Trial 3

Researcher
2
Trial 1
Trail 2

Trial 3

Average

M0

0

0

0

0

0

0

0.0

M1

0

0

0

5

5

5

2.5

M2

0

0

0

1

1

1

0.5

M3

0

0

0

1

1

1

0.5

Total
0.88
Average:

Supplemental Table 2. Marbles buried during marble burying protocol by Group 3 of male
C57BL/6J mice. Due to the availability of researchers, only two trained researchers participated,
but each person counted the number of marbles buried 3 times.
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C57BL/6J FEMALES
Performed:2-17-20
Researcher 1

Researcher 2

F1

0

1

Researcher 3 AVERAGE
2
1.0

F2

0

0

0

0.0

F3

5

13

10

9.3

F4

4

1

1

2.0

F5

8

14

12

11.3

F6

0

1

1

0.7

F7

1

4

3

2.7

F8

0

0

0

0.0

F9

1

3

2

2.0

F10

2

4

4

3.3

TOTAL
3.2
AVERAGAE
Supplemental Table 3. Marbles buried during marble burying protocol by Group 1 of female
C57BL/6J mice. The methods from Table 1 were repeated.
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Valproic Acid
Performed:
11-13-18
Researcher 1

Researcher 2

Researcher 3

AVERAGE

M1

0

0

2

0.7

M2

3

7

8

6.0

M3

0

1

4

1.7

M4

4

6

5

5.0

M5

0

2

2

1.3

M6

1

3

7

3.7

M7

1

1

5

2.3

TOTAL
2.95
AVERAGAE
Supplemental Table 4. Marbles buried during marble burying protocol by valproic acid males.
Methods from Table 2 were repeated.
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BTBR Performed:
11-30-18
Group 1

Researcher 1

Researcher 2

Researcher 3

AVERAGE

M1

7

7

6

6.7

M2

0

2

0

0.7

6

7

7

6.7

M4

9

9

8

8.7

M5

0

0

0

0.0

TOTAL
AVERAGAE

4.5

M3 ***had 24
total marbles***

Supplemental Table 5. Marbles buried during marble burying protocol by Group 1 of BTBR
males. Methods from Table 2 were repeated. M3 erroneously had 24 marbles placed during the
test instead of 20 marbles.
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BTBR
Performed:9-1619
Group 2

Trial 1

Trial 2

Trial 3

AVERAGE

M0

12

12

12

12

M1

10

11

11

10.7

M2

16

16

16

16

M3

5

5

5

5

M4

18

18

18

18

TOTAL
AVERAGE

12.3

Supplemental Table 6. Marbles buried during marble burying protocol by Group 2 of BTBR
males. Methods from Table 2 were repeated. M3 erroneously had 24 marbles placed during the
test instead of 20 marbles.
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Poly(I:C)
Performed:
3-21-19
Group 2

Researcher 1

Researcher 2

Researcher 3

AVERAGE

P5

12

13

13

12.7

P6

16

15

15

15.3

TOTAL
AVERAGE

12.3

Supplemental Table 7. Marbles buried during marble burying protocol by Group 2 of Poly(I:C)
males. Methods from Table 2 were repeated.
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Poly(I:C)
Performed:
4-30-19
Group 3

Researcher 1

Researcher 2

Researcher 3

AVERAGE

p10

3

6

4

4.3

p11

7

8

8

7.7

p12

0

0

0

0.0

p13

4

6

6

5.3

TOTAL
AVERAGE

4.3

Supplemental Table 8. Marbles buried during marble burying protocol by Group 2 of Poly(I:C)
males. Methods from Table 2 were repeated.
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Average SCFA per 80 mg of Sample
SCFA (%
Area Under
the Curve)
Acetate

Wild Type
Averages (mg)

Valproic Acid
Averages (mg)

BTBR
Averages (mg)

Poly (I:C)
Averages (mg)

10.49±1.295

6.180±0.340

6.81±0.415

9.31±0.206

Propionate

2.360±0.313

1.016±0.0317

1.198±0.077

1.892±0.021

Isobutyrate

0.178±0.034

0.0640±0.002

0.094±0.009

0.112±0.006

Butyrate

1.792±0.251

0.980±0.091

1.075±0.151

1.634±0.079

Isovalerate

0.192±0.039

0.054±0.003

0.234±0.155

0.096±0.004

Valerate

0.427±0.081

0.219±0.005

0.244±0.009

0.276±0.006

Supplemental Table 9. Average SCFA per 80 mg of Sample in Mouse Models of Social
Behavior
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105 Day Imaging (N=10)

21 Day Imaging (N=16)

C2206

C2208

C2209

C2211

B5003

C2212

B5004

C2213

B5005

C2215

B5022

C2229

V437

B5013

P2192

B5015

P3040

B5023

P3041

B5024
V425
V426
V427
V424
V446
P2188

Supplemental Table 10. Mice used for imaging.
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Supplemental Image 1. Measured tunica mucosa and tunica muscularis for C2213 at P21.
(N=7)
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Supplemental Image 2. Measured tunica mucosa and tunica muscularis for C57BL/6J P105
C2209. (N=2)

59

Supplemental Image 3. Measured tunica mucosa and tunica muscularis for BTBR P21 B5013.
(N=4)
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Supplemental Image 4. Measured tunica mucosa and tunica muscularis for BTBR P105 B5005.
(N=4)
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Supplemental Image 5. Measured tunica mucosa and tunica muscularis for valproic acid P21
V246. Image has been cropped for clarity. (N=6)
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Supplemental Image 6. Measured tunica mucosa and tunica muscularis for valproic acid P105
V437. This was the only sample for valproic acid P105. (N=1)
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Supplemental Image 7. Measured tunica mucosa and tunica muscularis for Poly(I:C) P21 2188.
The tissue shows desiccation. In future studies, if Poly(I:C) is included again, the tests will need
to be repeated given the unreliability of the samples. (N=2).
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Supplemental Image 8. Measured tunica mucosa and tunica muscularis for Poly(I:C) P105
P2192. (N=3)
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